These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17162283)

  • 1. Cardioplegic solutions and nitric oxide in coronary artery bypass surgery.
    Türköz R
    Anadolu Kardiyol Derg; 2006 Dec; 6(4):352. PubMed ID: 17162283
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of different cardioplegic solutions on nitric oxide release from coronary vasculature in diabetic patients undergoing coronary artery bypass surgery.
    Karaca P; Yurtseven N; Enç Y; Aksoy T; Sokullu O; Bilgen F; Canik S
    Anadolu Kardiyol Derg; 2006 Dec; 6(4):347-51. PubMed ID: 17162282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of statin therapy on stimulation of endothelium-derived nitric oxide before and after coronary artery bypass surgery.
    Sasmazel A; Baysal A; Fedekar A; Buyukbayrak F; Bugra O; Erdem H; Aydin C; Caliskan A; Sunar H
    Heart Surg Forum; 2010 Aug; 13(4):E243-6. PubMed ID: 20719727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide and cardiovascular system.
    Cengel A; Sahinarslan A
    Anadolu Kardiyol Derg; 2006 Dec; 6(4):364-8. PubMed ID: 17162286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supplementation of magnesium to warm blood hyperkalemic cardioplegia for the prevention of atrial fibrillation after coronary artery bypass grafting.
    Reşatoğlu AG; Uymaz OK; Akbulut B; Yener A
    Anadolu Kardiyol Derg; 2007 Jun; 7(2):230. PubMed ID: 17513237
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term outcome after coronary artery bypass grafting in patients with left ventricular dysfunction: does the type of cardioplegia matter?
    Ibrahim MF; Refaat AA
    Interact Cardiovasc Thorac Surg; 2008 May; 7(3):498. PubMed ID: 18495725
    [No Abstract]   [Full Text] [Related]  

  • 7. Endothelial dysfunction in patients with coronary atherosclerosis.
    Chapidze L; Kapanadze S; Dolidze N; Bakhutashvili Z; Latsabidze N
    Georgian Med News; 2007 Jan; (142):20-2. PubMed ID: 17327627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cardioplegic and organ preservation solutions and their components on coronary endothelium-derived relaxing factors.
    Yang Q; He GW
    Ann Thorac Surg; 2005 Aug; 80(2):757-67. PubMed ID: 16039259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide in homograft vein function.
    Chanda J; Kuribayashi R; Abe T
    Ann Thorac Surg; 1997 Nov; 64(5):1524-5. PubMed ID: 9386754
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug-eluting stents or drug-eluting conduits for multivessel disease?
    Alfieri O; Maisano F; Benussi S; Toracca L; Castiglioni A
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):359-61. PubMed ID: 17443103
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanisms of disease: L-arginine in coronary atherosclerosis--a clinical perspective.
    Tousoulis D; Böger RH; Antoniades C; Siasos G; Stefanadi E; Stefanadis C
    Nat Clin Pract Cardiovasc Med; 2007 May; 4(5):274-83. PubMed ID: 17457351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioplegic solution challenges.
    Menasché P
    Ital Heart J; 2000 Sep; 1 Suppl 3():S40-2. PubMed ID: 11003021
    [No Abstract]   [Full Text] [Related]  

  • 13. Does periadventitial fat-derived nitric oxide play a role in improved saphenous vein graft patency in patients undergoing coronary artery bypass surgery?
    Dashwood MR; Dooley A; Shi-Wen X; Abraham DJ; Souza DS
    J Vasc Res; 2007; 44(3):175-81. PubMed ID: 17308436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of low dose N-acetylcysteine (NAC) as an adjunct to cardioplegia in coronary artery bypass surgery.
    Köksal H; Rahman A; Burma O; Halifeoğlu I; Bayar MK
    Anadolu Kardiyol Derg; 2008 Dec; 8(6):437-43. PubMed ID: 19103540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prostacyclin production in internal mammary ano radial arteries and saphenous veins of diabetic and non diabetic subjects].
    Guivernau M; Berr M
    Rev Med Chil; 2008 Jul; 136(7):823-30. PubMed ID: 18949156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin in coronary artery disease.
    Pernow J
    Scand Cardiovasc J; 2004 Oct; 38(5):257-8. PubMed ID: 15513306
    [No Abstract]   [Full Text] [Related]  

  • 17. Relation of preoperative radial artery flow-mediated dilatation to nitric oxide bioavailability in radial artery grafts used in off-pump coronary artery bypass grafting.
    Antoniades C; Mussa S; Shirodaria C; Lee J; Diesch J; Taggart DP; Channon KM; Leeson P
    Am J Cardiol; 2009 Jan; 103(2):216-20. PubMed ID: 19121439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient beneficial effects of glutamate-aspartate-enriched cardioplegia on ventricular functions in coronary artery bypass grafting.
    Duman U; Dogan OF
    J Card Surg; 2006; 21(5):523-5. PubMed ID: 16948778
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diminished release of nitrogen monoxide from arteriosclerotic coronary vessels?].
    Förstermann U
    Dtsch Med Wochenschr; 1991 May; 116(19):758-9. PubMed ID: 2026113
    [No Abstract]   [Full Text] [Related]  

  • 20. [A new catheter for direct coronary artery perfusion].
    Matsuura A; Koyama T; Moriya H; Okamoto H; Yasuura K; Takeuchi E; Tanaka M; Murase M; Abe T; Hosino M
    Kyobu Geka; 1987 Oct; 40(11):902-3. PubMed ID: 3500349
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.